CN Patent

CN113490492A — 吡唑酰胺化合物的非晶质固体分散体

Assigned to Japan Tobacco Inc · Expires 2021-10-08 · 5y expired

What this patent protects

本发明的目的是提供药物动力学得到改善的含有式［I］的化合物或其制药上可接受的盐或其水合物的制剂、及其制造方法。本发明涉及含有（1）非晶质的式［I］所示的化合物或其制药上可接受的盐或其水合物、和（2）选自醋酸羟丙基甲基纤维素琥珀酸酯、甲基纤维素、羟丙甲纤维素和聚乙烯醇中的1～4种制药上可接受的聚合物的固体分散体、及其制造方法。

USPTO Abstract

本发明的目的是提供药物动力学得到改善的含有式［I］的化合物或其制药上可接受的盐或其水合物的制剂、及其制造方法。本发明涉及含有（1）非晶质的式［I］所示的化合物或其制药上可接受的盐或其水合物、和（2）选自醋酸羟丙基甲基纤维素琥珀酸酯、甲基纤维素、羟丙甲纤维素和聚乙烯醇中的1～4种制药上可接受的聚合物的固体分散体、及其制造方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN113490492A
Jurisdiction: CN
Classification: —
Expires: 2021-10-08
Drug substance claim: No
Drug product claim: No
Assignee: Japan Tobacco Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.